Context Therapeutics Inc. Banner Image

Context Therapeutics Inc.

  • Ticker CNTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Context Therapeutics Inc. Logo Image
  • 1-10 Employees
  • Based in Philadelphia, Pennsylvania
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company dedicated to improving the lives of patients living with cancer. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. CLDN6 is a tight junction membrane protein target expressed in multiple solid tumors, including ovarianMore, lung, and testicular, and absent from or expressed at low levels in healthy adult tissues. Context is headquartered in Philadelphia.
Context Therapeutics Inc.

Most Recent Annual Report

Context Therapeutics Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Context Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!